JP2024545507A5 - - Google Patents

Info

Publication number
JP2024545507A5
JP2024545507A5 JP2024534532A JP2024534532A JP2024545507A5 JP 2024545507 A5 JP2024545507 A5 JP 2024545507A5 JP 2024534532 A JP2024534532 A JP 2024534532A JP 2024534532 A JP2024534532 A JP 2024534532A JP 2024545507 A5 JP2024545507 A5 JP 2024545507A5
Authority
JP
Japan
Prior art keywords
approximately
vector
tnnc1
polynucleotide
promoter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534532A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545507A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081282 external-priority patent/WO2023108129A1/en
Publication of JP2024545507A publication Critical patent/JP2024545507A/ja
Publication of JP2024545507A5 publication Critical patent/JP2024545507A5/ja
Pending legal-status Critical Current

Links

JP2024534532A 2021-12-10 2022-12-09 Aavベクターを用いたトロポニンc(tnnc1)遺伝子治療 Pending JP2024545507A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163288255P 2021-12-10 2021-12-10
US63/288,255 2021-12-10
PCT/US2022/081282 WO2023108129A1 (en) 2021-12-10 2022-12-09 Troponin c (tnnc1) gene therapy using aav vector

Publications (2)

Publication Number Publication Date
JP2024545507A JP2024545507A (ja) 2024-12-09
JP2024545507A5 true JP2024545507A5 (cg-RX-API-DMAC7.html) 2025-10-29

Family

ID=86731323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534532A Pending JP2024545507A (ja) 2021-12-10 2022-12-09 Aavベクターを用いたトロポニンc(tnnc1)遺伝子治療

Country Status (6)

Country Link
US (1) US20240335566A1 (cg-RX-API-DMAC7.html)
EP (1) EP4444893A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024545507A (cg-RX-API-DMAC7.html)
CN (1) CN118613591A (cg-RX-API-DMAC7.html)
CA (1) CA3240616A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023108129A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102673203B1 (ko) 2016-04-20 2024-06-10 센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. Pklr의 유전자 발현 증강을 위한 조성물 및 방법
AU2018352583B2 (en) 2017-10-16 2025-04-17 Centro de Investigaciones Energeticas, Medioambientales Y Tecnologicas, O.A., M.P. Lentiviral vectors for delivery of PKLR to treat Pyruvate Kinase Deficiency
US12539316B2 (en) 2018-04-11 2026-02-03 Spacecraft Seven, Llc Compositions and methods for stem cell transplant
IL280465B2 (en) 2018-07-30 2025-03-01 Centro De Investig Energeticas Medioambientales Y Tecnologicas O A M P Methods for gene modification of hematopoietic cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5553547B2 (ja) * 2009-07-14 2014-07-16 俊一 梶岡 トロポニン含有医薬組成物
CA2837322C (en) * 2011-05-26 2023-03-21 University Of Washington Cell and gene based methods to improve cardiac function
EP2792742A1 (en) * 2013-04-17 2014-10-22 Universitätsklinikum Hamburg-Eppendorf (UKE) Gene-therapy vectors for treating cardiomyopathy
WO2018178067A1 (en) * 2017-03-27 2018-10-04 Vrije Universiteit Brussel Diaphragm-specific nucleic acid regulatory elements and methods and use thereof
CN114450411A (zh) * 2019-04-01 2022-05-06 特纳亚治疗股份有限公司 具有工程化衣壳的腺相关病毒
AR126660A1 (es) * 2021-07-28 2023-11-01 Univ Brussel Vrije Mejorando la eficacia de la terapia génica dirigida a músculos

Similar Documents

Publication Publication Date Title
JP2023538519A5 (cg-RX-API-DMAC7.html)
JP2023536618A5 (cg-RX-API-DMAC7.html)
JP2024546103A5 (cg-RX-API-DMAC7.html)
JP2025512574A5 (cg-RX-API-DMAC7.html)
US20220331409A1 (en) Factor ix gene therapy
JP2025179046A5 (cg-RX-API-DMAC7.html)
IL278213B1 (en) A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
JP2023536902A5 (cg-RX-API-DMAC7.html)
AU2021320902A1 (en) Plakophilin-2 (PKP2) gene therapy using AAV vector
JP2024523707A5 (cg-RX-API-DMAC7.html)
JP2024099770A5 (cg-RX-API-DMAC7.html)
JP2022520232A5 (cg-RX-API-DMAC7.html)
JP2023535576A5 (cg-RX-API-DMAC7.html)
JP2023088902A5 (cg-RX-API-DMAC7.html)
JP2025515979A5 (cg-RX-API-DMAC7.html)
JP2022531861A5 (cg-RX-API-DMAC7.html)
JP2022541793A5 (cg-RX-API-DMAC7.html)
JP2025505662A5 (cg-RX-API-DMAC7.html)
JP2021533805A5 (cg-RX-API-DMAC7.html)
JP2021500922A5 (cg-RX-API-DMAC7.html)
US12486518B2 (en) Bicistronic AAV vectors encoding hexosaminidase alpha and beta-subunits and uses thereof
JP2023537903A5 (cg-RX-API-DMAC7.html)
JP2023537980A5 (cg-RX-API-DMAC7.html)
JP2023503850A5 (cg-RX-API-DMAC7.html)
JP2021520232A5 (cg-RX-API-DMAC7.html)